Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence
Authors
Keywords
-
Journal
Obesity
Volume 31, Issue 5, Pages 1280-1289
Publisher
Wiley
Online
2023-03-31
DOI
10.1002/oby.23736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
- (2022) Domenica M. Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes
- (2022) Wahiba Elhag et al. OBESITY SURGERY
- Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population
- (2022) Amgad Mentias et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Current state of the definition and terminology related to weight recurrence after metabolic surgery: review by the POWER Task Force of the American Society for Metabolic and Bariatric Surgery
- (2022) Saniea F. Majid et al. Surgery for Obesity and Related Diseases
- Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
- (2022) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the U.S.
- (2021) Karine Suissa et al. DIABETES OBESITY & METABOLISM
- Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
- (2021) Andres Acosta et al. Obesity
- Pharmacotherapies for Post‐Bariatric Weight Regain: Real‐World Comparative Outcomes
- (2021) Chellse L. Gazda et al. Obesity
- Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission
- (2021) Douglas Barthold et al. DIABETES CARE
- Safety of Semaglutide
- (2021) Mark M. Smits et al. Frontiers in Endocrinology
- Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
- (2021) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study
- (2021) Beverly G. Tchang et al. Obesity Science & Practice
- The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux‐en‐Y Gastric Bypass Surgery
- (2020) Nawfal W. Istfan et al. Obesity
- Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
- (2019) Alexander Dimitri Miras et al. Lancet Diabetes & Endocrinology
- Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
- (2019) David R. Saxon et al. Obesity
- US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
- (2017) G Gomez et al. INTERNATIONAL JOURNAL OF OBESITY
- The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study
- (2017) Fatima Cody Stanford et al. Surgery for Obesity and Related Diseases
- Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment of Weight Recidivism or Weight Loss Plateau Post-bariatric Surgery: a Retrospective Review
- (2015) Jennifer Schwartz et al. OBESITY SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now